Literature DB >> 8858398

The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy.

J P Mulhall1, R J Graydon.   

Abstract

OBJECTIVE: Despite the advent of the nerve-sparing radical retropubic prostatectomy (NSRRP) a significant number of men still suffer from post radical prostatectomy impotence. The purpose of this study was to investigate the pathogenesis of erectile dysfunction following NSRRP and to define the previously reported vascular mechanism. Furthermore, it was our goal to clarify the respective contributions of arterial and venous components. PATIENTS AND METHODS: Sixteen potent males with localized prostate carcinoma underwent dynamic infusion cavernosometry preoperatively to assess arterial and venous hemodynamics. Ten of these men were impotent following the operation and had repeat cavernosometric evaluation six months postoperatively.
RESULTS: On cavernosometry all 10 patients had arterial insufficiency on at least one side, six patients had bilateral changes. The mean reduction in CAOP was 50% (range 30-70%). Four patients met criteria for the diagnosis of corporovenocclusive dysfunction on cavernosometry.
CONCLUSIONS: These data strongly support a vascular mechanism in the genesis of post-NSRRP impotence. This mechanism is predominantly arterial in nature, but some men have a mixed pattern with both arterial and venous components. The postoperative arterial insufficiency may be the result of intraoperative injury to the accessory pudendal artery. The exact means by which CVOD develops in this situation remains unclear at this time.

Entities:  

Mesh:

Year:  1996        PMID: 8858398

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  15 in total

1.  Transplantation of nonhematopoietic adult bone marrow stem/progenitor cells isolated by p75 nerve growth factor receptor into the penis rescues erectile function in a rat model of cavernous nerve injury.

Authors:  Muammer Kendirci; Landon Trost; Benjamin Bakondi; Mandolin J Whitney; Wayne J G Hellstrom; Jeffrey L Spees
Journal:  J Urol       Date:  2010-08-21       Impact factor: 7.450

2.  Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art.

Authors:  Tariq Al Shaiji; Trustin Domes; Gerald Brock
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

Review 3.  [Pathophysiology and rehabilitation of erectile dysfunction after nerve-sparing radical prostatectomy].

Authors:  C van der Horst; F J Martinez-Portillo; K P Jünemann
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

4.  Therapeutic strategies for localized prostate cancer I: surgery, ultrasound, adjuvant and neoadjuvant therapy.

Authors:  M I Resnick; E D Crawford; M E Gleave; J Lynch; J P Mulhall; K Pummer; G Vallancien
Journal:  Rev Urol       Date:  2000

Review 5.  The current and potential role of cryoablation as a primary therapy for localized prostate cancer.

Authors:  Aaron E Katz; John C Rewcastle
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

Review 6.  Erectile dysfunction and treatment of carcinoma of the prostate.

Authors:  Culley C Carson; J Slade Hubbard; Eric Wallen
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 3.092

Review 7.  Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management.

Authors:  Kalyana C Nandipati; Rupesh Raina; Ashok Agarwal; Craig D Zippe
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 8.  The role and structure of a postradical prostatectomy penile rehabilitation program.

Authors:  John P Mulhall
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

9.  Vacuum therapy ameliorates erectile dysfunction in bilateral cavernous nerve crush rats by inhibiting apoptosis and activating autophagy.

Authors:  Chang-Jing Wu; Fu-Dong Fu; Feng Qin; Ming Ma; Tao Li; Shan-Zun Wei; Bo-Tao Yu; Xin-Zong Yang; Jiu-Hong Yuan
Journal:  Asian J Androl       Date:  2021 May-Jun       Impact factor: 3.285

Review 10.  Focal or subtotal therapy for early stage prostate cancer.

Authors:  J Stephen Jones
Journal:  Curr Treat Options Oncol       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.